{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T09:14:02Z","timestamp":1768295642739,"version":"3.49.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,1,9]],"date-time":"2020-01-09T00:00:00Z","timestamp":1578528000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,1,9]],"date-time":"2020-01-09T00:00:00Z","timestamp":1578528000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Linyi Science and Technology Bureau","award":["201818019"],"award-info":[{"award-number":["201818019"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cardiothorac Surg"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Percutaneous closure of patent foramen ovale (PFO) is routinely performed using plain fluoroscopy in the catheter room. This method results in inevitable radiation damage, adverse effects of contrast agents on kidneys, and high cost. We performed PFO closure with a simplified and economical transesophageal echocardiography (TEE)-only guided approach in the operating room. This study aimed to investigate the feasibility, safety, and effectiveness of the percutaneous closure of PFO by only using TEE.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>We reviewed the medical records of patients who underwent percutaneous PFO closure at our center from December 2013 to December 2017. A total of 132 patients with PFO and cryptogenic strokes underwent PFO closure by using cardi-O-fix PFO device under TEE guidance. The participants comprised 64 and 68 male and female patients, respectively. The mean age and body weight of the patients were 39.40\u2009\u00b1\u200913.22\u2009years old (12\u201368\u2009years old) and 65.42\u2009\u00b1\u20099.70\u2009kg (40\u201395\u2009kg), respectively. All patients only received aspirin (3\u20135\u2009mg\/kg body weight, oral administration) for 6\u2009months. Contrast-enhanced transthoracic echocardiography (c-TTE) with Valsalva maneuver was performed during follow-up, and questionnaire surveys were obtained at 3, 6, and 12\u2009months after the procedure.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>All (100%) patients were successfully closed. Follow-ups were conducted for 13\u2009months to 48\u2009months, with an average of 27\u2009months. No severe complications were found during the follow-up period. Paroxysmal atrial fibrillation occurred in 4 patients within 3\u2009months after the procedure. No recurrent stroke or death occurred in all patients during the follow-up period. Transient ischemic attack occurred in one patient 6\u2009months after the procedure. Ten (7.6%) patients had a right-to-left shunt, as demonstrated by c-TTE at 12\u2009months of follow-up. Among the 57 patients suffering from migraine, significant relief or resolution was reported by 42 (73.7%) patients.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p>TEE-only guided PFO closure was a safe, feasible, and effective method that did not require the use of X-rays and contrast agents.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s13019-020-1042-4","type":"journal-article","created":{"date-parts":[[2020,1,9]],"date-time":"2020-01-09T17:03:50Z","timestamp":1578589430000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Patent foramen ovale closure by using transesophageal echocardiography for cryptogenic stroke: single center experience in 132 consecutive patients"],"prefix":"10.1186","volume":"15","author":[{"given":"Yangyang","family":"Han","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiquan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fengwei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,1,9]]},"reference":[{"key":"1042_CR1","doi-asserted-by":"publisher","first-page":"129","DOI":"10.2174\/1574887112666170328124939","volume":"12","author":"AS Manolis","year":"2017","unstructured":"Manolis AS. Impact of percutaneous closure of interatrial shunts on migraine attacks: single-operator series and review of the literature. Rev Recent Clin Trials. 2017;12:129\u201338.","journal-title":"Rev Recent Clin Trials"},{"key":"1042_CR2","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.ihj.2017.07.020","volume":"70","author":"AS Manolis","year":"2018","unstructured":"Manolis AS, Koulouris S, Rouska E. Simplified percutaneous closure of patent foramen ovale and atrial septal defect with use of plain fluoroscopy: single operator experience in 110 consecutive patients. Indian Heart J. 2018;70:24\u201331.","journal-title":"Indian Heart J"},{"key":"1042_CR3","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1056\/NEJMoa1707404","volume":"377","author":"L S\u00f8ndergaard","year":"2017","unstructured":"S\u00f8ndergaard L, Kasner SE, Rhodes JF, et al. Patent foramen Ovale closure or antiplatelet therapy for cryptogenic stroke. N Engl J Med. 2017;377:1033\u201342.","journal-title":"N Engl J Med"},{"key":"1042_CR4","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1016\/j.jacc.2012.01.086","volume":"60","author":"J Tobis","year":"2012","unstructured":"Tobis J, Shenoda M. Percutaneous treatment CNY of patent foramen ovale and atrial septal defects. J Am Coll Cardiol. 2012;60:1722\u201332.","journal-title":"J Am Coll Cardiol"},{"key":"1042_CR5","first-page":"377","volume":"7","author":"G Butera","year":"2011","unstructured":"Butera G, Biondi-Zoccai G, Sangiorgi G, Abella R, Giamberti A, Bussadori C, et al. Percutaneous versus surgical closure of secundum atrial septal defects: a systematic review and meta-analysis of currently available clinical evidence. Euro Intervention. 2011;7:377\u201385.","journal-title":"Euro Intervention"},{"key":"1042_CR6","first-page":"e652","volume":"12","author":"Y Yang","year":"2016","unstructured":"Yang Y, Zhang W, Wu Q, Gao L, Jin W, Zhao T. Transcatheter closure of atrial septal defects without fluoroscopy: a well established procedure for alternative use in children. Euro Intervention. 2016;12:e652\u20137.","journal-title":"Euro Intervention"},{"key":"1042_CR7","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1007\/s12519-018-0179-x","volume":"14","author":"WZ Xu","year":"2018","unstructured":"Xu WZ, Shou XY, Li JH, et al. Non-fluoroscopic percutaneous transcatheter closure of atrial septal defects in children under transesophageal echocardiographic guidance. World J Pediatr. 2018;14:378\u201382.","journal-title":"World J Pediatr"},{"key":"1042_CR8","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1111\/joic.12214","volume":"28","author":"XB Pan","year":"2015","unstructured":"Pan XB, Ou-Yang WB, Pang KJ, et al. Percutaneous closure of atrial Septal defects under transthoracic echocardiography guidance without fluoroscopy or intubation in children. J Interv Cardiol. 2015;28:390\u20135.","journal-title":"J Interv Cardiol"},{"key":"1042_CR9","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1023\/A:1026119331193","volume":"12","author":"M Kosinski","year":"2003","unstructured":"Kosinski M, Bayliss MS, Bjorner JB, et al. A six-item short-form survey for measuring headache impact: the HIT-6. Qual Life Res. 2003;12:963\u201374.","journal-title":"Qual Life Res"},{"key":"1042_CR10","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1159\/000075794","volume":"17","author":"JF Meschia","year":"2004","unstructured":"Meschia JF, Lojacono MA, Miller MJ, et al. Reliability of the questionnaire for verifying stroke-free status. Cerebrovasc Dis. 2004;17:218\u201323.","journal-title":"Cerebrovasc Dis"},{"key":"1042_CR11","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1007\/s11910-018-0910-y","volume":"18","author":"HC Diener","year":"2018","unstructured":"Diener HC, Gerloff C, Thaler DE. Closure of patent foramen Ovale and cryptogenic stroke: unresolved issues. Curr Neurol Neurosci Rep. 2018;18:92.","journal-title":"Curr Neurol Neurosci Rep"},{"key":"1042_CR12","first-page":"373","volume":"27","author":"Branch of cardiovascular physicians of Chinese physicians association","year":"2015","unstructured":"Branch of cardiovascular physicians of Chinese physicians association. Chinese expert advice on the management strategy of patent foramen ovale. Chinese Heart Journal. 2015;27:373\u20139 (in Chinese).","journal-title":"Chinese Heart Journal"},{"key":"1042_CR13","doi-asserted-by":"publisher","unstructured":"Vukadinovi\u0107 D, Schirmer SH, Vukadinovi\u0107 AN, et al. Interventional closure vs medical therapy of patent foramen ovale for secondary prevention of stroke: updated meta-analysis. Clin Res Cardiol. 2018. https:\/\/doi.org\/10.1007\/s00392-018-1334-z.","DOI":"10.1007\/s00392-018-1334-z"},{"key":"1042_CR14","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.amjmed.2017.11.027","volume":"131","author":"M Vaduganathan","year":"2018","unstructured":"Vaduganathan M, Qamar A, Gupta A, et al. Patent foramen Ovale closure for secondary prevention of cryptogenic stroke: updated meta-analysis of randomized clinical trials. Am J Med. 2018;131:575\u20137.","journal-title":"Am J Med"},{"key":"1042_CR15","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1093\/eurheartj\/ehy121","volume":"39","author":"Y Ahmad","year":"2018","unstructured":"Ahmad Y, Howard JP, Arnold A, et al. Patent foramen ovale closure vs. medical therapy for cryptogenic stroke: a meta-analysis of randomized controlled trials. Eur Heart J. 2018;39:1638\u201349.","journal-title":"Eur Heart J"},{"key":"1042_CR16","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/s00392-012-0445-1","volume":"101","author":"S Schubert","year":"2012","unstructured":"Schubert S, Kainz S, Peters B, et al. Interventional closure of atrial septal defects without fluoroscopy in adult and pediatric patients. Clin Res Cardiol. 2012;101:691\u2013700.","journal-title":"Clin Res Cardiol"},{"key":"1042_CR17","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/1749-8090-6-48","volume":"6","author":"QK Guo","year":"2011","unstructured":"Guo QK, Lu ZQ, Cheng SF, et al. Off-pump occlusion of trans-thoracic minimal invasive surgery (OPOTTMIS) on simple congenital heart diseases (ASD, VSD and PDA) attached consecutive 210 cases report: a single institute experience. J Cardiothorac Surg. 2011;6:48. https:\/\/doi.org\/10.1186\/1749-8090-6-48.","journal-title":"J Cardiothorac Surg"},{"key":"1042_CR18","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.athoracsur.2014.03.029","volume":"98","author":"L Hongxin","year":"2014","unstructured":"Hongxin L, Zhang N, Wenbin G, et al. Peratrial device closure of perimembranous ventricular septal defects through a right parasternal approach. Ann Thorac Surg. 2014;98:668\u201374.","journal-title":"Ann Thorac Surg"},{"key":"1042_CR19","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1111\/echo.14055","volume":"35","author":"Y Liu","year":"2018","unstructured":"Liu Y, Guo GL, Wen B, et al. Feasibility and effectiveness of percutaneous balloon mitral valvuloplasty under echocardiographic guidance only. Echocardiography. 2018;35:1507\u201311.","journal-title":"Echocardiography"},{"key":"1042_CR20","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.jjcc.2012.12.005","volume":"61","author":"S Sathasivam","year":"2013","unstructured":"Sathasivam S, Sathasivam S. Patent foramen ovale and migraine: what is the relationship between the two? J Cardiol. 2013;61:256\u20139.","journal-title":"J Cardiol"},{"key":"1042_CR21","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1111\/head.12618","volume":"55","author":"N Kahya Eren","year":"2015","unstructured":"Kahya Eren N, B\u00fclb\u00fcl NG, Yakar T\u00fcl\u00fcce S, et al. To be or not to be patent: the relationship between migraine and patent foramen Ovale. Headache. 2015;55:934\u201342.","journal-title":"Headache"},{"key":"1042_CR22","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.jjcc.2015.09.016","volume":"67","author":"H Takagi","year":"2016","unstructured":"Takagi H, Umemoto T. A meta-analysis of case-control studies of the association of migraine and patent foramen ovale. J Cardiol. 2016;67:493\u2013503.","journal-title":"J Cardiol"},{"key":"1042_CR23","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1111\/joic.12296","volume":"29","author":"J Moon","year":"2016","unstructured":"Moon J, Kang WC, Kim S, et al. Comparison of outcomes after device closure with Transseptal puncture and standard technique in patients with patent foramen Ovale and ischemic events. J Interv Cardiol. 2016;29:400\u20135. https:\/\/doi.org\/10.1111\/joic.12296.","journal-title":"J Interv Cardiol"},{"key":"1042_CR24","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1016\/j.jcin.2018.03.008","volume":"11","author":"AH Shah","year":"2018","unstructured":"Shah AH, Osten M, Benson L, et al. Incidence and outcomes of positive bubble contrast study results after Transcatheter closure of a patent foramen Ovale. JACC Cardiovasc Interv. 2018;11:1095\u2013104.","journal-title":"JACC Cardiovasc Interv"}],"container-title":["Journal of Cardiothoracic Surgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-020-1042-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13019-020-1042-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-020-1042-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,8]],"date-time":"2021-01-08T01:01:53Z","timestamp":1610067713000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiothoracicsurgery.biomedcentral.com\/articles\/10.1186\/s13019-020-1042-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,9]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1042"],"URL":"https:\/\/doi.org\/10.1186\/s13019-020-1042-4","relation":{},"ISSN":["1749-8090"],"issn-type":[{"value":"1749-8090","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,9]]},"assertion":[{"value":"25 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study has been approved by the Medical Ethics Committee of Linyi People\u2019s Hospital Affiliated to Shandong University (No. 20014).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"For the 132 cases in our institution, consents for publication have been obtained from patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11"}}